Compare CZFS & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZFS | CNXU |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 282.3M |
| IPO Year | 1995 | N/A |
| Metric | CZFS | CNXU |
|---|---|---|
| Price | $74.12 | $8.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.6K | ★ 113.0K |
| Earning Date | 04-29-2026 | N/A |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 30.26 | N/A |
| EPS | ★ 2.16 | N/A |
| Revenue | ★ $9,881,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.64 | N/A |
| P/E Ratio | $33.10 | ★ N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $49.99 | $8.14 |
| 52 Week High | $75.00 | $13.66 |
| Indicator | CZFS | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 57.59 | 36.33 |
| Support Level | $54.77 | N/A |
| Resistance Level | $74.70 | $11.45 |
| Average True Range (ATR) | 3.30 | 1.48 |
| MACD | -0.13 | -0.10 |
| Stochastic Oscillator | 90.03 | 6.52 |
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.